Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.23.1
Income Taxes (Tables)
12 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Provision (Benefit) for Income Taxes
The components of the Company’s income tax provision (benefit) attributable to operations are as follows:
Year ended March 31,
2023 2022 2021
Current:
U.S. federal $ (38) $ 236  $ — 
State and local 637  703  204 
Non-U.S. 10,313  7,439  38 
10,912  8,378  242 
Deferred:
U.S. federal 3,026  1,485  (13,185)
State and local (3,430) (1,350) (204)
Non-U.S. (5,362) (110) 120 
(5,766) 25  (13,269)
Income tax provision (benefit) $ 5,146  $ 8,403  $ (13,027)
Reconciliation of Income Tax Expense Between Statutory U S Income Tax Rate With Actual Income Tax Provision
A reconciliation of income tax expense using the statutory U.S. income tax rate compared with the actual income tax provision (benefit) follows:
Year ended March 31,
2023 2022 2021
Statutory federal income taxes $ 4,650  $ 9,256  $ 8,819 
State income taxes, net of federal benefit 77  938  (1,284)
State rate remeasurement (2,992) —  — 
Non-deductible expenses 67  2,891  926 
Disallowed executive compensation 1,070  —  — 
Excess deductions for stock compensation 1,167  (9,946) (16,523)
Foreign income inclusion, net 3,926  —  — 
Foreign rate differential (2,682) (1,554) — 
Change in Mobile Posse earn-out —  —  3,238 
Change in Fyber earn-out —  10,500  — 
Change in AdColony earn-out —  (1,872) — 
Research and development tax credit (3,000) —  — 
Change in uncertain tax liability 600  52  591 
Change in valuation allowance 6,500  (1,503) (11,223)
Return-to-provision adjustments (4,237) (454) 2,243 
Other miscellaneous —  95  186 
Income tax provision (benefit) $ 5,146  $ 8,403  $ (13,027)
Deferred Tax Assets and Liabilities
Deferred income tax assets and liabilities consist of the following:
Year ended March 31,
2023 2022 2021
Deferred income tax assets
Net operating loss carry-forward $ 63,660  $ 76,219  $ 25,630 
Stock-based compensation 7,009  3,765  1,675 
Accrued compensation 1,562  3,724  1,968 
Capitalized research and experimentation expenses 4,965  —  — 
Other 1,366  1,700  1,919 
Gross deferred income tax assets 78,562  85,408  31,192 
Valuation allowance (25,921) (19,914) (5,287)
Net deferred income tax assets 52,641  65,494  25,905 
Deferred income tax liabilities
Depreciation and amortization (2,063) (5,795) (2,627)
Intangibles and goodwill (64,518) (79,675) (10,315)
Net deferred income tax assets (liabilities) $ (13,940) $ (19,976) $ 12,963 
Summary of Operating Loss Carryforwards
The following details the scheduled expiration dates of the Company’s net operating loss (NOL) carryforwards:
2024 Through 2033 2034 Through 2043 Indefinite Total
U.S. federal NOLs $ —  $ 45,741  $ 49,828  $ 95,569 
State taxing jurisdictions NOLs 6,487  103,636  1,395  111,518 
Non-U.S. NOLs —  —  128,683  128,683 
Total, net $ 6,487  $ 149,377  $ 179,906  $ 335,770 
Schedule of Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits
A reconciliation of the beginning and ending amounts of unrecognized tax benefits for the years ended March 31, 2023, 2022, and 2021, is as follows:
Year ended March 31,
  2023 2022 2021
Balance at April 1 $ 1,424  $ 1,372  $ 787 
Additions for tax positions of prior years 600  52  585 
Reductions for tax positions of prior years —  —  — 
Balance at March 31 $ 2,024  $ 1,424  $ 1,372